Bayer's Monsanto unit urged a Missouri judge to approve its $7.25 billion proposed settlement of lawsuits alleging that its weedkiller Roundup causes ​cancer, saying there is no other way to resolve the litigation that has weighed on the German company for years. More here

What happened

Bayer's Monsanto unit asked a Missouri judge to approve its proposed $7.25 billion settlement of lawsuits claiming its Roundup weedkiller causes cancer. Bayer says this is the only way to resolve litigation that has burdened the German company for years.

Confirmed

Global impact / market context

If the judge approves the settlement, Bayer will pay $7.25 billion to resolve many cancer lawsuits. This removes a big financial worry, but still leaves other cases and future claims, which could affect Bayer's profits and cash available for years.

Analyst inference

This settlement is connected to Bayer's Monsanto unit. Investors have watched this legal issue for years because large payouts could reduce Bayer's cash available for other spending. The judge's decision will show how much this legal problem will cost the company going forward.

Analyst inference

What to watch

1. Watch whether the Missouri judge approves the proposed $7.25 billion settlement. The judge's decision will confirm if this is the final cost for these specific Roundup cancer lawsuits. Confirmed
2. Bayer proposed this settlement as the only way to resolve the litigation. Watch if the judge accepts this argument or if other legal options are considered, which could change the final payment amount. Proposed
3. Watch for news about any remaining Roundup lawsuits not covered by this settlement. Those cases could still require additional payments, which would further reduce Bayer's cash available for other business investments. Analyst inference

Evidence

• x.com